CANNABIS SCIENCE - Revolution oder Verblendung ?
Seite 52 von 141 Neuester Beitrag: 25.04.21 01:13 | ||||
Eröffnet am: | 21.09.12 08:26 | von: Brokerface03. | Anzahl Beiträge: | 4.518 |
Neuester Beitrag: | 25.04.21 01:13 | von: Inesrhtla | Leser gesamt: | 723.070 |
Forum: | Hot-Stocks | Leser heute: | 238 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 49 | 50 | 51 | | 53 | 54 | 55 | ... 141 > |
Cannabis Science Orders Multiple Greenhouse Structures for its 2nd Pilot 33,000 Sq. Ft. Drug Development Facility Buildout in Douglas County, Nevada
IRVINE, CA -- (Marketwired) -- 12/21/16 -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medications, has started work on its second 33,000 sq. ft. pilot cannabinoid drug development and manufacturing facility in Douglas County, Nevada.
"We have every intention of making 2017 the breakout year for our great company. To fast track our second pilot greenhouse and property build program, we ordered prefabricated and regular greenhouses. This second pilot property will house some of our grow operations and research and development activity. Our target is to begin growing a variety of prime strains in the first quarter of 2017," said CEO Raymond C. Dabney. "We need all the drug development capacity we can get, because we intend to ramp up our operations to meet the increased demand for cannabinoid medications across the country. This market is coming into full-bloom, and 2017 is the year we will be positioned to capitalize on this tremendous opportunity."
The Douglas County, Nevada multi-phased project is the second pilot site and is currently in full buildout of greenhouses, water-well development, extraction points, and manufacturing. The grow operations at this site will support the extraction of cannabinoids for the development of key proprietary formulations. The site management team is in place, and the labor crew is being hired locally to create jobs and economic benefits to the community. This multi-phased facility is officially under construction.
"The first quarter of 2017 will be an exciting time for more new product releases and much larger distribution channels. We will utilize various medication delivery methods (such as pills, creams, extracts, inhalers, tinctures, and balms) based on the ailment and we will release our cannabinoid-based medications across the country. I can't emphasis enough what an exciting and busy year 2017 looks to be," stated CBIS CEO Raymond C. Dabney.
Cannabis Science is mapping out strategic demographic analyses across the country for full circle operations in each area: Grow, Lab Extraction, Manufacturing and Dispensaries. Having R&D and full circle operations and facilities in one site will allow Cannabis Science to bring its product to market more rapidly than before, while trimming costs for acquisition, extraction, and medication manufacturing. While the company will place high emphasis on producing its existing product lines to meet the demand of current distributors, Cannabis Science will continue and expand the work on developing new product lines, which will allow them to access new patients across the country.
With over 3,500 acres in its portfolio in California and Nevada and much more under negotiations for future drug development projects, the company has a unique opportunity to scale out this model very quickly across the Western United States. Once this pilot buildout project in Nevada is complete and functional, the company will work on expanding its operations across the country.
Und siehe da was wieder im Soll.
Noch 16% im Minus. Vielleicht doch keine Depotleiche.
Kann mich ja nicht ständig wiederholen.
Wer hier long geht macht nichts falsch.
Klar wird es auch 30-40 % rückwärts geben, aber ich bremse als Letzter.
Am Montag könnten wir schon 15 Cent überschreiten. Dann wären wir zwei Tage schneller als mein Plan und noch genug Druck auf dem Kessel.
Wenn wir nächste Woche die 20 Cent schaffen, sind wir vor Ostern beim halben $.
CBIS hat bisher alles richtig gemacht. Land nachgekauft, sich mit Harvard Cancer Research, eines der besten Labore mit Personal verbunden und erste Schmerzpflaster entwickelt. Wenn die Anträge auf Zulassung neuer Wirkstoffe und Medikamente bei der FDA ankommen, geht sie durch die Decke.
Es gibt auch Eilverfahren gerade bei Krebs- und Schmerzbehandlung, aber 1-2 Jahre kann das noch dauern.
Es ist jedem freigestellt zu verkaufen...
Seid nett zu euren Familien und erholt euch gut.
Ich glaube an 14-15 Cent morgen, eine technische Korrektur wird langsam wahrscheinlicher, kann aber auch erst bei 18-25 Cent erfolgen. Bei CBIS ist der Himmel voller Geigen.